Vascular risk factors and Alzheimer's disease—a new therapeutic opportunity?

Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment. Metabolic and genetic factors involved in increasing the probability of developing dementia have already been identified. Some vascular risk factors, as hypertension, dyslipidaemia, diabetes or smoking can cause a derangement in extra or intracranial vessels architecture, which can be responsible for an early aging of the brain. However, reliable tools for early identification of subjects at greater risk of evolution from mild cognitive impairment to AD are not available.

In a recent study, a research group from the Neurological Clinic of the University Hospital Ospedali Riuniti di Ancona and Marche Polytechnic University, Ancona, Italy, evaluated the reliability of the Framingham cardiovascular risk profile (FCRP) for the prediction of the evolution from to AD. FCRP is a commonly adopted score used to calculate the risk of cardiovascular or cerebrovascular events along a 10-year period. Authors selected FCRP to evaluate if some common conditions, such as hypertension or diabetes, could be involved in increasing the risk of developing dementia. The results of this study are published in the Journal of Alzheimer's Disease.

The study, coordinated by Mauro Silvestrini and Leandro Provinciali with Giovanna Viticchi as principal investigator, demonstrated that in subjects affected by mild cognitive impairment, the presence of high FCRP scores is associated to an increased risk of developing AD. These results could have a relevant impact on the management of dementia because prevention of and treatment of vascular damage can reduce the incidence of AD. Reducing and preventing the progression of could represent a main therapeutic target for the prevention of .


Explore further

Cardiac disease linked to higher risk of mental impairment

More information: Giovanna Viticchi et al. Framingham Risk Score and the Risk of Progression from Mild Cognitive Impairment to Dementia, Journal of Alzheimer's Disease (2017). DOI: 10.3233/JAD-170160
Journal information: Journal of Alzheimer's Disease

Provided by IOS Press
Citation: Vascular risk factors and Alzheimer's disease—a new therapeutic opportunity? (2017, August 2) retrieved 28 September 2021 from https://medicalxpress.com/news/2017-08-vascular-factors-alzheimer-diseasea-therapeutic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors